Uploaded May 2026 | Updated September 2026, 3 weeks ago
In this episode, Dr Louise Newson is joined by US-based surgeon Dr Lee Howard to discuss the rise of neurokinin receptor antagonists, including fezolinetant, and what this means for the health of women.
While these drugs can reduce hot flushes, Dr Louise and Lee question whether treating a single symptom risks overlooking the wider impact of hormone deficiency on long-term health. They explore how these medications work, potential unknown effects and the concern that symptom relief may give a false sense of reassurance.
The conversation highlights the need to move beyond a symptom-focused approach and recognise menopause as a whole-body condition, ensuring women have clear, balanced information to make informed choices about their care.
In this episode, Dr Louise Newson is joined by US-based surgeon Dr Lee Howard to discuss the rise of neurokinin receptor antagonists, including fezolinetant, and what this means for the health of women.
While these drugs can reduce hot flushes, Dr Louise and Lee question whether treating a single symptom risks overlooking the wider impact of hormone deficiency on long-term health. They explore how these medications work, potential unknown effects and the concern that symptom relief may give a false sense of reassurance.
The conversation highlights the need to move beyond a symptom-focused approach and recognise menopause as a whole-body condition, ensuring women have clear, balanced information to make informed choices about their care.
